CMND

$0.00

(

+0.00%

) Quote details
Add to Watchlist Run Backtest
stock

Clearmind Medicine Inc. Common Shares

NASDAQ | CMND

1.19

USD

+$0.00

(

+0.00%

)

At Close (As of Sep 19, 2025)

$5.38M

Market Cap

-

P/E Ratio

-0.75

EPS

$2.18

52 Week High

$0.80

52 Week Low

HEALTHCARE

Sector

CMND Chart

Recent Chart
Price Action

CMND Technicals

Tags:

CMND Earnings

Yearly Income Statement (As of Oct 31, 2024)

Field Value (CAD)
Gross Profit -$27K
Total Revenue $0
Cost Of Revenue $27K
Costof Goods And Services Sold $27K
Operating Income -$8M
Selling General And Administrative $3.3M
Research And Development $1.4M
Operating Expenses $8M
Investment Income Net -
Net Interest Income $235K
Interest Income $271K
Interest Expense $36K
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $17K
Income Before Tax -$4.9M
Income Tax Expense $378K
Interest And Debt Expense -
Net Income From Continuing Operations -$5.3M
Comprehensive Income Net Of Tax -
Ebit -$8M
Ebitda -$8M
Net Income -$5.3M

Revenue & Profitability

Earnings Performance

CMND Financials

yearly Balance Sheet (As of Oct 31, 2024)

Field Value (CAD)
Total Assets $7.3M
Total Current Assets $7.1M
Cash And Cash Equivalents At Carrying Value $6.6M
Cash And Short Term Investments $6.6M
Inventory -
Current Net Receivables $181K
Total Non Current Assets $167K
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets $108K
Intangible Assets Excluding Goodwill $108K
Goodwill -
Investments -
Long Term Investments -
Short Term Investments $289K
Other Current Assets $44K
Other Non Current Assets -
Total Liabilities $4.1M
Total Current Liabilities $4.1M
Current Accounts Payable $526K
Deferred Revenue -
Current Debt -
Short Term Debt $73K
Total Non Current Liabilities $16K
Capital Lease Obligations $53K
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $53K
Other Current Liabilities $3.5M
Other Non Current Liabilities -
Total Shareholder Equity $3.1M
Treasury Stock -
Retained Earnings -$24M
Common Stock $24M
Common Stock Shares Outstanding $4.3M

yearly Cash Flow (As of Oct 31, 2024)

Field Value (CAD)
Operating Cashflow -$4.9M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $51K
Capital Expenditures $0
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment -$238K
Cashflow From Financing $6.3M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$5.3M

yearly Income Statement (As of Oct 31, 2024)

Field Value (CAD)
Gross Profit -$27K
Total Revenue $0
Cost Of Revenue $27K
Costof Goods And Services Sold $27K
Operating Income -$8M
Selling General And Administrative $3.3M
Research And Development $1.4M
Operating Expenses $8M
Investment Income Net -
Net Interest Income $235K
Interest Income $271K
Interest Expense $36K
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $17K
Income Before Tax -$4.9M
Income Tax Expense $378K
Interest And Debt Expense -
Net Income From Continuing Operations -$5.3M
Comprehensive Income Net Of Tax -
Ebit -$8M
Ebitda -$8M
Net Income -$5.3M

CMND News

CMND Profile

Clearmind Medicine Inc. Common Shares Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Clearmind Medicine Inc. (CMND) is a preclinical pharmaceutical company based in Vancouver, Canada, dedicated to the development of innovative psychedelic therapies aimed at addressing unmet medical needs. With a focus on neglected health issues, Clearmind is pioneering research into psychedelic compounds that have the potential to redefine treatment paradigms in mental health. The company's robust pipeline reflects its commitment to advancing novel therapeutic solutions through rigorous scientific investigation and regulatory compliance.

CJET
+187.16%
$0.29
YAAS
+15.23%
$0.08
ADAP
-9.75%
$0.14
NVDA
+0.24%
$176.67
INTC
-3.23%
$29.58
AGMH
+363.67%
$10.34
HOOD
+3.20%
$124.78
CGBS
-39.47%
$0.03
SNAP
-3.25%
$8.16
WBD
+3.36%
$19.32
AAPL
+3.20%
$245.50
PLUG
+3.80%
$2.18
RAYA
-1.65%
$0.05
RGTI
+15.27%
$28.52
DNN
+3.89%
$2.67
PLTR
+3.06%
$182.39
BTG
+3.93%
$4.49
BITF
-2.50%
$3.12
BAC
+0.23%
$52.25
AMZN
+0.10%
$231.48
FAAS
-10.53%
$0.08
QUBT
+26.40%
$23.19
TSLA
+2.21%
$426.07
PFE
-0.49%
$24.03
ATCH
-21.84%
$0.91
QBTS
+11.85%
$26.86
AAL
-1.03%
$12.45
NIO
0.00%
$7.37
SOUN
+2.78%
$16.06
SOFI
+4.98%
$29.51
QS
+10.63%
$13.42
APP
+4.51%
$649.59
DVLT
+8.82%
$0.45
TPIC
-45.91%
$0.12
MULN
-16.93%
$0.05
BMNR
+1.35%
$60.77
EQX
+3.84%
$10.80
AXDX
-61.36%
$0.03
MARA
-1.13%
$18.29
OKLO
+28.82%
$135.22
JOBY
+13.32%
$16.57
RR
-0.89%
$4.45
AMC
+5.98%
$3.01
CAN
-5.06%
$0.77
GOOGL
+1.06%
$254.72
LYT
-16.77%
$0.09
RIVN
-2.40%
$14.32
AMD
-0.33%
$157.38
RXRX
-0.40%
$4.91
TTD
+1.22%
$44.47
MSFT
+1.86%
$517.92
F
-0.93%
$11.62
SMR
+22.69%
$46.77
IONQ
+5.38%
$70.41
ABEV
0.00%
$2.29
BINI
-3.72%
$0.04
KVUE
+1.32%
$18.34
IONZ
-10.89%
$4.09
AMCR
-0.60%
$8.26
CSCO
-0.68%
$68.20
CLSK
+1.18%
$13.62
CDE
+7.00%
$17.42
ACHR
+7.02%
$9.90
VHAI
0.00%
$0.00
VTRS
+0.40%
$9.90
KEY
-0.26%
$19.07
RIG
-4.04%
$3.32
BBD
+1.68%
$3.32
ZOOZ
+7.29%
$2.50
KDLY
-6.04%
$1.40
NAKA
-6.04%
$1.40
GRAB
+0.11%
$6.35
BLMZ
+2.81%
$0.17
NEM
+4.34%
$81.72
GOOG
+1.15%
$255.24
CDLX
-9.65%
$2.48
AVGO
-0.11%
$344.94
NGD
+2.56%
$6.60
RMBL
+60.50%
$3.21
CIFR
+3.62%
$12.28
ORCL
+4.05%
$308.66
WULF
+2.01%
$11.39
UBER
+4.02%
$98.51
ADD
-25.47%
$0.05
ITUB
+1.38%
$7.33
CMND
+19.00%
$1.19
MPW
-0.59%
$5.01
MP
+1.51%
$73.22
RVPH
-36.43%
$0.26
HST
-1.02%
$17.42
AMRZ
-3.48%
$50.40
CMG
-1.23%
$39.32
GPUS
-3.34%
$0.51
LAES
+18.83%
$4.29
NTNX
-1.36%
$77.09
IREN
+6.38%
$38.64
WFC
+1.34%
$84.62
EOSE
+8.44%
$9.76
KTOS
+0.14%
$80.77
RIOT
+0.45%
$17.59
CJET
+187.16%
$0.29
YAAS
+15.23%
$0.08
ADAP
-9.75%
$0.14
NVDA
+0.24%
$176.67
INTC
-3.23%
$29.58
AGMH
+363.67%
$10.34
HOOD
+3.20%
$124.78
CGBS
-39.47%
$0.03
SNAP
-3.25%
$8.16
WBD
+3.36%
$19.32
AAPL
+3.20%
$245.50
PLUG
+3.80%
$2.18
RAYA
-1.65%
$0.05
RGTI
+15.27%
$28.52
DNN
+3.89%
$2.67
PLTR
+3.06%
$182.39
BTG
+3.93%
$4.49
BITF
-2.50%
$3.12
BAC
+0.23%
$52.25
AMZN
+0.10%
$231.48
FAAS
-10.53%
$0.08
QUBT
+26.40%
$23.19
TSLA
+2.21%
$426.07
PFE
-0.49%
$24.03
ATCH
-21.84%
$0.91
QBTS
+11.85%
$26.86
AAL
-1.03%
$12.45
NIO
0.00%
$7.37
SOUN
+2.78%
$16.06
SOFI
+4.98%
$29.51
QS
+10.63%
$13.42
APP
+4.51%
$649.59
DVLT
+8.82%
$0.45
TPIC
-45.91%
$0.12
MULN
-16.93%
$0.05
BMNR
+1.35%
$60.77
EQX
+3.84%
$10.80
AXDX
-61.36%
$0.03
MARA
-1.13%
$18.29
OKLO
+28.82%
$135.22
JOBY
+13.32%
$16.57
RR
-0.89%
$4.45
AMC
+5.98%
$3.01
CAN
-5.06%
$0.77
GOOGL
+1.06%
$254.72
LYT
-16.77%
$0.09
RIVN
-2.40%
$14.32
AMD
-0.33%
$157.38
RXRX
-0.40%
$4.91
TTD
+1.22%
$44.47
MSFT
+1.86%
$517.92
F
-0.93%
$11.62
SMR
+22.69%
$46.77
IONQ
+5.38%
$70.41
ABEV
0.00%
$2.29
BINI
-3.72%
$0.04
KVUE
+1.32%
$18.34
IONZ
-10.89%
$4.09
AMCR
-0.60%
$8.26
CSCO
-0.68%
$68.20
CLSK
+1.18%
$13.62
CDE
+7.00%
$17.42
ACHR
+7.02%
$9.90
VHAI
0.00%
$0.00
VTRS
+0.40%
$9.90
KEY
-0.26%
$19.07
RIG
-4.04%
$3.32
BBD
+1.68%
$3.32
ZOOZ
+7.29%
$2.50
KDLY
-6.04%
$1.40
NAKA
-6.04%
$1.40
GRAB
+0.11%
$6.35
BLMZ
+2.81%
$0.17
NEM
+4.34%
$81.72
GOOG
+1.15%
$255.24
CDLX
-9.65%
$2.48
AVGO
-0.11%
$344.94
NGD
+2.56%
$6.60
RMBL
+60.50%
$3.21
CIFR
+3.62%
$12.28
ORCL
+4.05%
$308.66
WULF
+2.01%
$11.39
UBER
+4.02%
$98.51
ADD
-25.47%
$0.05
ITUB
+1.38%
$7.33
CMND
+19.00%
$1.19
MPW
-0.59%
$5.01
MP
+1.51%
$73.22
RVPH
-36.43%
$0.26
HST
-1.02%
$17.42
AMRZ
-3.48%
$50.40
CMG
-1.23%
$39.32
GPUS
-3.34%
$0.51
LAES
+18.83%
$4.29
NTNX
-1.36%
$77.09
IREN
+6.38%
$38.64
WFC
+1.34%
$84.62
EOSE
+8.44%
$9.76
KTOS
+0.14%
$80.77
RIOT
+0.45%
$17.59
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.